418 related articles for article (PubMed ID: 36922356)
21. Adult-type and Pediatric-type Diffuse Gliomas : What the Neuroradiologist Should Know.
Nafe R; Porto L; Samp PF; You SJ; Hattingen E
Clin Neuroradiol; 2023 Sep; 33(3):611-624. PubMed ID: 36941392
[TBL] [Abstract][Full Text] [Related]
22. Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.
Delfanti RL; Piccioni DE; Handwerker J; Bahrami N; Krishnan A; Karunamuni R; Hattangadi-Gluth JA; Seibert TM; Srikant A; Jones KA; Snyder VS; Dale AM; White NS; McDonald CR; Farid N
J Neurooncol; 2017 Dec; 135(3):601-609. PubMed ID: 28871469
[TBL] [Abstract][Full Text] [Related]
23. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
Malzkorn B; Reifenberger G
Pathologe; 2019 Jun; 40(Suppl 1):9-17. PubMed ID: 31025086
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.
Iuchi T; Sugiyama T; Ohira M; Kageyama H; Yokoi S; Sakaida T; Hasegawa Y; Setoguchi T; Itami M
Brain Tumor Pathol; 2018 Apr; 35(2):71-80. PubMed ID: 29470683
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Gritsch S; Batchelor TT; Gonzalez Castro LN
Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
[TBL] [Abstract][Full Text] [Related]
26. Classification of adult-type diffuse gliomas: Impact of the World Health Organization 2021 update.
Whitfield BT; Huse JT
Brain Pathol; 2022 Jul; 32(4):e13062. PubMed ID: 35289001
[TBL] [Abstract][Full Text] [Related]
27. Major Features of the 2021 WHO Classification of CNS Tumors.
Smith HL; Wadhwani N; Horbinski C
Neurotherapeutics; 2022 Oct; 19(6):1691-1704. PubMed ID: 35578106
[TBL] [Abstract][Full Text] [Related]
28. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA
Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847
[TBL] [Abstract][Full Text] [Related]
29. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.
Ramkissoon SH; Fernandes H; Lopez-Terrada DH; Hameed MR; Trembath DG; Bridge JA; Lindeman NI; Souers RJ; Vasalos P; Brat DJ; Moncur JT
Arch Pathol Lab Med; 2022 May; 147(5):518-524. PubMed ID: 35878398
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
Tabouret E; Nguyen AT; Dehais C; Carpentier C; Ducray F; Idbaih A; Mokhtari K; Jouvet A; Uro-Coste E; Colin C; Chinot O; Loiseau H; Moyal E; Maurage CA; Polivka M; Lechapt-Zalcman E; Desenclos C; Meyronet D; Delattre JY; Figarella-Branger D;
Acta Neuropathol; 2016 Oct; 132(4):625-34. PubMed ID: 27573687
[TBL] [Abstract][Full Text] [Related]
31. Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis.
Aboian MS; Tong E; Solomon DA; Kline C; Gautam A; Vardapetyan A; Tamrazi B; Li Y; Jordan CD; Felton E; Weinberg B; Braunstein S; Mueller S; Cha S
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1804-1810. PubMed ID: 31694820
[TBL] [Abstract][Full Text] [Related]
32. Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report.
van der Meulen M; Ramos RC; Mason WP; Von Deimling A; Maas SLN
Neurology; 2022 Nov; 99(20):903-908. PubMed ID: 36240081
[TBL] [Abstract][Full Text] [Related]
33. A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted.
Santosh V; Rao S
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S14-S23. PubMed ID: 35562130
[TBL] [Abstract][Full Text] [Related]
34. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
[TBL] [Abstract][Full Text] [Related]
35. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
Bale TA; Jordan JT; Rapalino O; Ramamurthy N; Jessop N; DeWitt JC; Nardi V; Alvarez MM; Frosch M; Batchelor TT; Louis DN; Iafrate AJ; Cahill DP; Lennerz JK
Neuro Oncol; 2019 May; 21(5):596-605. PubMed ID: 30496526
[TBL] [Abstract][Full Text] [Related]
36. Paediatric type diffuse high grade gliomas in the WHO CNS5 classification: What the pathologist needs to know?
Rao S; Sahay A; Epari S
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S50-S58. PubMed ID: 35562134
[TBL] [Abstract][Full Text] [Related]
37. [Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors. German version].
Malzkorn B; Reifenberger G
Pathologe; 2019 Mar; 40(2):131-139. PubMed ID: 30790013
[TBL] [Abstract][Full Text] [Related]
38. Clinical roles of
Wang H; Zhang X; Liu J; Chen W; Guo X; Wang Y; Wang Y; Xing H; Liang T; Shi Y; Liu D; Yang T; Xia Y; Li J; Wu J; Liu Q; Qu T; Guo S; Li H; Zhang K; Li Y; Jin S; Zhao D; Wang Y; Ma W
Front Neurosci; 2024; 18():1308627. PubMed ID: 38595969
[TBL] [Abstract][Full Text] [Related]
39. Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors.
Kurokawa R; Kurokawa M; Baba A; Ota Y; Pinarbasi E; Camelo-Piragua S; Capizzano AA; Liao E; Srinivasan A; Moritani T
Radiographics; 2022; 42(5):1474-1493. PubMed ID: 35802502
[TBL] [Abstract][Full Text] [Related]
40. Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation.
Aboian MS; Solomon DA; Felton E; Mabray MC; Villanueva-Meyer JE; Mueller S; Cha S
AJNR Am J Neuroradiol; 2017 Apr; 38(4):795-800. PubMed ID: 28183840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]